Travere Therapeutics, Inc.
Travere Therapeutics, Inc. (TVTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · TVTX · as of Jun 8, 2026
Key Statistics
Explore Travere Therapeutics, Inc. Data
tvtx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 83.3%
The TVTX analyst consensus is Buy, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $56.67, representing +19.66% upside from the current price of $47.36.
Competitors & Peers
tvtx competitorsTVTX
AAPG
APGE
CELC
CGON
CNTAStock Performance
Full HistoryAbout Travere Therapeutics, Inc.
Travere Therapeutics, Inc. a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed pro…
what is travere therapeutics, inc. · tvtx stock overview · travere therapeutics, inc. company profile · who is travere therapeutics, inc. ceo · tvtx NASDAQ · travere therapeutics, inc. headquarters · travere therapeutics, inc. business segments
About Stock Overview & Key Data
Travere Therapeutics, Inc. (TVTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 8, 2012. As of the latest trading session, TVTX stock price is $47.36, with a market capitalization of $4.4B. The stock has returned +218.65% over the past 12 months and +24.34% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Travere Therapeutics, Inc. stock is Buy, with an average 12-month price target of $56.67. In fiscal year 2025, Travere Therapeutics, Inc. reported revenue of $490.7M and net income of -$25.5M. For detailed data — including Travere Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Travere Therapeutics, Inc. (TVTX) stock price is $47.36. The stock is traded on NASDAQ under the ticker symbol TVTX. The 52-week range is $13.88 – $48.61.